With this kind of mild cognitive impairment, a person activities cognitive decline in areas in addition to memory. It would be problems with reasoning, judgment, language or interaction.The extension analyze also evaluated CLARITY AD individuals who had a delayed start off (individuals that switched from placebo to lecanemab after the core trial) a